Clinical Trials Sponsored by Immune Pharmaceuticals

Total 20062 results

Ligand Pharmaceuticals
CyDex Pharmaceuticals, Inc.

Withdrawn

Comparison of Captisol-Enabled™ Iohexol and Omnipaque™ in Patients With Impaired Renal Function Undergoing Coronary Angiography

Contrast-induced Nephropathy
Paratek Pharmaceuticals Inc
Novartis Pharmaceuticals

Terminated

Study the Safety and Efficacy of PTK 0796 in Patients With Complicated Skin and Skin Structure Infection (CSSSI) (CSSI)

Skin Diseases, Infectious

United States
Vertex Pharmaceuticals Incorporated
Janssen Pharmaceuticals

Terminated

An Open-Label Study of the Effect of Telaprevir in Combination With Peginterferon Alfa-2b and Ribavirin in Pediatric Subjects Infected With Hepatitis C Virus

Hepatitis C

United States, United Kingdom, Spain, Belgium, Italy, Germany
Eleison Pharmaceuticals LLC.
Threshold Pharmaceuticals

Completed

Safety and Efficacy Study of Glufosfamide in Previously Treated Advanced Soft Tissue Sarcoma

Soft Tissue Sarcoma

United States
Johnson & Johnson Pharmaceutical Research & Development...
Janssen Pharmaceutica N.V., Belgium

Completed

A Safety and Dose-finding Study of JNJ-26481585 for Patients With Advanced Solid Malignancies and Lymphoma.

Neoplasms | Lymphoma

United Kingdom
Shenzhen Geno-Immune Medical Institute
The Second Affiliated Hospital of Hainan Medical University

Recruiting

Universal CAR-T Cells Targeting Multiple Myeloma

Multiple Myeloma in Remission

China
Shenzhen Geno-Immune Medical Institute
Shenzhen Second People's Hospital; Shenzhen Third People's Hospital

Recruiting

Safety and Immunity of Covid-19 aAPC Vaccine

Treat and Prevent Covid-19 Infection

China
Chumakov Federal Scientific Center for Research...

Completed

Observational Program, Study the Preventive Efficacy of the BiVac Polio Vaccine Against the Incidence of Acute Respiratory Infections, Including COVID-19

Coronavirus Infections | Polio | Vaccine

Russian Federation
Nucorion Pharmaceuticals, Inc.
Ligand Pharmaceuticals

Completed

Activity of NCO-48 Fumarate in Treatment-Naive Adults With Chronic Hepatitis B

Chronic Hepatitis B

United States
Semafore Pharmaceuticals
SignalRX Pharmaceuticals, Inc.

Completed

A Dose Escalation Study of SF1126, a PI3 Kinase (PI3K) Inhibitor, Given By Intravenous (IV) Infusion in Patients With Solid Tumors (SF112600106)

Cancer | Advanced or Metastatic Solid Tumors | Solid Cancers

United States
Conatus Pharmaceuticals Inc.
Idun Pharmaceuticals

Completed

A Caspase Inhibitor in Chronic Hepatitis C (HCV) Patients

Hepatitis C, Chronic

United States
Conatus Pharmaceuticals Inc.
Idun Pharmaceuticals

Completed

Safety and Efficacy Study of a Caspase Inhibitor in Patients Undergoing Liver Transplantation

Liver Transplantation | Hepatitis | Carcinoma, Hepatocellular | Cholestasis

United States, Germany
Inimmune Corporation
Avance Clinical Pty Ltd.

Not yet recruiting

Trial of INI-4001 in Patients With Advanced Solid Tumours

Advanced Solid Tumor

Australia
Inimmune Corporation
Avance Clinical Pty Ltd.

Recruiting

Trial of INI-2004 in Healthy Volunteers and Participants With Allergic Rhinitis.

Allergic Rhinitis | Allergic Rhinitis Due to Weed Pollen

Australia
Immutep S.A.S.
Merck Sharp & Dohme LLC

Active, not recruiting

Combination Study With Soluble LAG-3 Fusion Protein Eftilagimod Alpha (IMP321) and Pembrolizumab in Patients With Previously Untreated Unresectable or Metastatic NSCLC, or Recurrent PD-X Refractory NSCLC or With Recurrent or Metastatic HNSCC (TACTI-002)

NSCLC | HNSCC

Spain, United States, United Kingdom, Australia, Ukraine
Haydarpasa Numune Training and Research Hospital

Completed

Kinesio Tape Application With EDF Technique on Active Trigger Points of Upper Trapezius Muscle

Myofascial Pain Syndrome | Myofascial Trigger Point Pain

Turkey
Haydarpasa Numune Training and Research Hospital

Unknown

The Effect of Intradermal Local Anesthetic Injection in FBSS (Failed Back Surgery Syndrome) (FBSS)

Pain, Chronic | Failed Back Surgery Syndrome
Adana Numune Training and Research Hospital

Completed

Atopic Diseases & Human Papilloma Virus

Human Papilloma Virus | Atopic Asthma | Atopic Disorders

Turkey
Adana Numune Training and Research Hospital

Completed

Limberg and Karydakis Flap in Recurrent Pilonidal Sinus Disease

Recurrent Pilonidal Sinus Disease
National Institute of Allergy and Infectious Diseases...
Regeneron Pharmaceuticals; PPD; Rho Federal Systems Division, Inc.; ALK-Abelló A/S and other collaborators

Active, not recruiting

Grass Pollen Immunotherapy Plus Dupilumab for Tolerance Induction (GRADUATE)

Grass Pollen Allergy | Allergic Rhinoconjunctivitis

United Kingdom
Johnson & Johnson Pharmaceutical Research & Development...
Janssen Pharmaceutica N.V., Belgium

Completed

A Safety and Dose-finding Study of JNJ-26483327, a Drug in Development for Cancer, for Patients With Advanced and/or Refractory Solid Malignancies.

Pharmacokinetics | Advanced Malignancies | Solid Malignancies | Protein Kinase Inhibitors | Maximum Tolerated Dose | Antineoplastic Protocols | Clinical Trial, Phase 1
National Institute of Allergy and Infectious Diseases...
Immuno-US

Completed

A Phase I Multicenter Clinical Trial to Evaluate the Safety and Immunogenicity of Vaccinia Derived HIV-1 Recombinant Envelope Glycoprotein (gp160) of Human Immunodeficiency Virus: Evaluation of Accelerated Schedules

HIV Infections

United States
NuGenerex Immuno-Oncology
Merck Sharp & Dohme LLC; NSABP Foundation Inc

Active, not recruiting

Establishing the Recommended Biological Dose for AE37 Peptide Vaccine in Combination With Pembrolizumab That Will Enhance the Tumor-specific Immune Response and Demonstrate Efficacy in Patients With Advanced Triple-negative Breast Cancer (NSABP FB-14)

Triple-negative Breast Cancer

United States
San Antonio Military Medical Center
NuGenerex Immuno-Oncology; Norwell, Inc.

Completed

Vaccine Therapy in Treating Patients With Breast Cancer

Breast Cancer

United States, Germany, Greece
National Institute of Allergy and Infectious Diseases...
Immunex Corporation

Completed

Recombinant Human IL-4 Receptor Used in Treatment of Asthma

Asthma
Shenzhen Geno-Immune Medical Institute
The Seventh Affiliated Hospital of Sun Yat-sen University

Recruiting

Multi-4SCAR-T Therapy Targeting Breast Cancer

Breast Cancer

China
Second Affiliated Hospital of Guangzhou Medical...
Tcell Immune (Guangzhou) Science and Technology Ltd.

Recruiting

TCR-T Cell Immunotherapy of Lung Cancer and Other Solid Tumors

Nonsmall Cell Lung Cancer | Solid Tumor, Adult

China
University Hospital, Lille
FAI²R (Auto-immune and auto-inflammatory rare diseases French network)

Terminated

Mental Health Consequences of COVID19 Infection in the French RMD Cohort (MentCovid19RMD)

Covid19 | Inflammatory Rheumatism | Systemic Autoimmune Disease | Auto Inflammatory Diseases

France
Shenzhen Geno-Immune Medical Institute
Shenzhen Children's Hospital; Shenzhen Hospital of Southern Medical University

Unknown

Immune Modulatory DC Vaccine Against Brain Tumor

Diffuse Intrinsic Pontine Glioma or Glioblastoma

China
University Hospital, Lille
FAI²R (Auto-immune and auto-inflammatory rare diseases French network)

Unknown

Covid-19 in Patients With Chronic Inflammatory Rheumatism, Auto-immune or Auto-inflammatory Rare and Non-rare Diseases (covid19 fai2r)

Autoimmune Diseases | Sars-CoV2 | Chronic Inflammatory Rheumatism

France
Institut Bergonié
Bristol-Myers Squibb; Amgen; Aventis Pharmaceuticals; Sanofi-Synthelabo; Chugai Pharmaceutical

Completed

Development of an Evaluation Method of Elderly Condition in Patient Receiving Chemotherapy Treatment (PHRC2003)

Digestive System Diseases | Lymphoma | Ovarian Diseases | Pulmonary Disease | Bladder Disease | Prostatic Disease

France
Haydarpasa Numune Training and Research Hospital

Recruiting

Correlation of Cervical Lordosis Degree Detected on Cervical X-Ray Image With Clinical, Demographic and MRI Findings

Neck Pain | Disk, Herniated | Cervical Lordosis

Turkey
Assistance Publique - Hôpitaux de Paris
Immunov

Terminated

Immunological Response to COVID-19 Vaccine in Patients With Autoimmune and Inflammatory Diseases Treated With Immunosuppressants and/or Biologics (COVADIS)

Autoimmune Diseases | Inflammatory Disorder

France
Mustafa Balevi,MD
Konya Numune Hospital

Completed

The Effect of Centella Asiatica Cream on Scar Tenderness Who Underwent Open Carpal Tunnel Release Surgery

To Prevent Scar Formation for Patients Underwent Surgery

Turkey
Immunic AG
FGK Clinical Research GmbH

Completed

A Study to Evaluate the Efficacy, Safety and Tolerability of IMU-838 as Addition to Investigator's Choice of Standard of Care Therapy, in Patients With Coronavirus Disease 19 (COVID-19)

COVID-19

Bulgaria, Germany
Haydarpasa Numune Training and Research Hospital

Completed

Efficacyof Pilates Exercises in Lowback Pain (RCT)

Low Back Pain | Physical Therapy | Pilates

Turkey
Københavns Kommune
Copenhagen University Hospital, Hvidovre

Completed

Exercise for People With Peripheral Neuropathy and Diabetic Foot Ulcers - a Case Series on Feasibility and Safety

Diabetes Mellitus | Foot Ulcer

Denmark
Haydarpasa Numune Training and Research Hospital

Completed

The Effectiveness of Ankaferd Blood Stopper in the Management of Traumatic Bleeding

Bleeding Disorder

Turkey
Adana Numune Training and Research Hospital

Completed

Hyperemesis Gravidarum and Osteoporosis

Hyperemesis Gravidarum
Adana Numune Training and Research Hospital

Unknown

Comparison of Perioperative Outcomes of Three Different Instruments in Total Laparoscopic Hysterectomy

Perioperative Outcomes

Turkey
Immutep S.A.S.
SGS Aster-Cephac (CRO)

Completed

Phase I Study of IMP321 Given Alone or as an Adjuvant to a Reference Flu Antigen

Healthy

France
Foresee Pharmaceuticals Co., Ltd.
QPS Holdings LLC; Changchun GeneScience Pharmaceutical Co., Ltd.

Recruiting

Efficacy, Safety, and Pharmacokinetics of Leuprolide Mesylate in Subjects With Central Precocious Puberty

Puberty; Precocious, Central

United States, China, Taiwan, Puerto Rico
Henan Cancer Hospital
Qilu Pharmaceutical Co., Ltd.; Beijing Biostar Pharmaceuticals Co., Ltd.

Not yet recruiting

Utidelone Combined With Bevacizumab in the Treatment of ≥ 2 Lines of HER-2 Negative Advanced Breast Cancer

HER-2 Negative Breast Cancer
National Institute of Allergy and Infectious Diseases...
Immuno-US

Completed

A Phase I Multicenter Clinical Trial to Evaluate the Safety and Immunogenicity of Vaccinia-Derived HIV-1 Recombinant Envelope Glycoprotein (gp160)

HIV Infections

United States
National Institute of Allergy and Infectious Diseases...
Immune Tolerance Network (ITN); Repligen Corporation

Completed

Safety of RG2077 in Patients With Multiple Sclerosis

Multiple Sclerosis | Multiple Sclerosis, Relapsing-Remitting

United States
Haydarpasa Numune Training and Research Hospital

Recruiting

Has Ultrasound-guided Hydrorelease of Coracohumeral Ligamet Additional Benefit in Patients With Adhesive Capsulitis Receiving Ultrasound-guided Shoulder Hyrodilatation?

Adhesive Capsulitis

Turkey
Immutep S.A.S.
Merck Sharp & Dohme LLC

Recruiting

Combination Study With Eftilagimod Alpha (a Soluble LAG-3 Fusion Protein) and Pembrolizumab in Patients With Recurrent or Metastatic HNSCC (TACTI-003)

HNSCC

United States, Belgium, Spain, United Kingdom, Denmark, Germany, Australia, Romania, Ukraine
Haydarpasa Numune Training and Research Hospital

Completed

Unexpected Diagnosis in Right Lower Quadrant Pain: Right Colon Diverticulitis

Diverticulitis, Colonic

Turkey
Haydarpasa Numune Training and Research Hospital

Completed

The Efficiency of Dry Needling and Cold Spray-stretching Treatments

Myofascial Pain Syndromes | Myofascial Trigger Point Pain

Turkey
Adana Numune Training and Research Hospital

Completed

Red Cell Distribution Width as a Predictor of Mortality in Acute Methanol Poisoning

Methanol Poisoning

Turkey

Clinical Trials Sponsored by Immune Pharmaceuticals

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Ireland

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations